CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-30 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | Harsanyi Zsolt Chairman | Grant or award | +34,403 | 123,732 | ||
| 2025-04-30 | Harsanyi Zsolt Chairman | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | DeGolyer Donald W Director | Grant or award | +34,403 | 145,503 | ||
| 2025-04-30 | DeGolyer Donald W Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | SULLIVAN LOUIS W Director | Grant or award | +34,403 | 139,098 | ||
| 2025-04-30 | SULLIVAN LOUIS W Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-07 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −561 | $4.44 | $2K | 109,122 |
| 2025-04-07 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −480 | $4.44 | $2K | 176,176 |
| 2025-03-12 | Fowler Neal Franklin Director | Sale | −35,000 | $5.83 | $204K | 101,100 |
| 2025-03-12 | Zoon Kathryn C Director | Sale | −10,000 | $5.73 | $57K | 44,482 |
| 2025-03-12 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +250,000 | 1,282,500 | ||
| 2025-03-12 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +250,000 | 1,532,500 | ||
| 2025-03-06 | Hartzel William SVP, Bioservices | Grant or award | +62,500 | 109,683 | ||
| 2025-03-06 | Perl Jessica SVP, General Counsel, Corp Sec | Grant or award | +62,500 | 68,387 | ||
| 2025-03-06 | Perl Jessica SVP, General Counsel, Corp Sec | Grant or award · Employee Stock Options (Right to Buy) | +62,500 | 95,945 | ||
| 2025-03-06 | Williams Paul Anthony SVP, Products Business | Grant or award | +62,500 | 86,335 | ||
| 2025-03-06 | Williams Paul Anthony SVP, Products Business | Grant or award · Employee Stock Options (Right to Buy) | +62,500 | 210,114 | ||
| 2025-03-06 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award | +146,888 | 299,225 | ||
| 2025-03-06 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award · Employee Stock Options (Right to Buy) | +178,546 | 484,490 |
Page 6 of 17 · 330 trades